Expert Opinion on Drug Metabolism & Toxicology

Papers
(The H4-Index of Expert Opinion on Drug Metabolism & Toxicology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Probing the mechanism of reduced in vivo potency of insulin detemir139
A three-arm clinical study to compare pharmacokinetic and pharmacodynamic similarity of the denosumab biosimilar LY06006 with reference denosumab in healthy male subjects60
The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update55
Comorbidities and the right dose: antipsychotics55
A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database54
Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney diseas38
Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis36
The Central Role of Cytochrome P450 Reductase (CPR) in Hyperoxic Lung Injury34
Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury31
Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata31
Hormones, microbes, and PrEP drugs in the female genital tract26
Tirabrutinib–anthracycline interactions in the brain tumor microenvironment: a focus on metabolic inactivation and resistance26
Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?26
Guidance for interactions between antiseizure medications26
Bioactivity descriptors for in vivo toxicity prediction: now and the future25
Immune-mediated liver injury caused by immune checkpoint inhibitors exhibits distinct clinical features that differ from autoimmune hepatitis25
Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine25
Pharmacokinetics and pharmacodynamics of approved monoclonal antibody therapy for colorectal cancer24
Pharmacokinetic evaluation of concizumab for the treatment of hemophilia23
A comprehensive review of the efficacy and safety of ertugliflozin21
Correction20
0.07436990737915